DKMS Foundation India Launches Free HLA Typing Program for Children with Thalassaemia

Access to matched donor transplantation for transfusion-dependent thalassaemia in pediatric patients hinges on one diagnostic bottleneck: HLA typing. DKMS Foundation India has moved to remove that barrier, launching a program that provides HLA typing at no cost to children under 12 diagnosed with transfusion-dependent thalassaemia.

The initiative targets a patient cohort where allogeneic hematopoietic stem cell transplantation remains the only curative option, yet donor matching rates in India are constrained by limited registry depth and the cost of upstream diagnostics. By absorbing HLA typing costs, DKMS Foundation India is addressing the pre-transplant diagnostic gap that frequently delays or forecloses transplant eligibility assessments for this population.

For transplant center QA leads and clinical operations teams, the program introduces a structured referral pathway that will require coordination with DKMS Foundation India's typing infrastructure. Centers managing pediatric thalassaemia caseloads should assess how incoming HLA data from this program integrates with existing donor search workflows and transplant registry protocols.

The broader supply-chain read is that expanded HLA typing volume, if sustained, could increase pressure on transplant centers to process a higher volume of donor search requests, with downstream implications for staffing, turnaround benchmarks, and registry submission timelines.

Program uptake and the number of children successfully matched to donors will serve as the measurable indicators of whether removing the typing cost barrier meaningfully shifts transplant access rates in this indication.

Source: Media4Growth via Indian Pharma Post, 6 May 2026.